On the recordSeptember 12, 2017
To spur innovation, a manufacturer would have to come to the table with essential human data, data that the drug will work on humans, will be safe and effective on humans.
Source
congress.govTo spur innovation, a manufacturer would have to come to the table with essential human data, data that the drug will work on humans, will be safe and effective on humans.
Gene Green discusses the need for human data to promote innovation in drug manufacturing.
Share
More from Gene Green
These numbers are troubling as we are because even more acute when you look at the existing racial, socioeconomic, and geographic disparities.
Mr. Chairman, thank you for holding today's hearing on the Implementation of the 21st Century Cures Act.
I was surprised after I got up and talked about MACRA and how we are trying to stay attuned to it as members of Congress, watching what the agency does.